Affinity of monoclonal antibodies for Globo-series glycans

le Eller, Chelcie H., Yang, Guangbin, Ouerfelli, Ouathek, Raines, Ronald T.
Foilsithe in Carbohydr Res (2014)

Synthesis of Human Cancer Associated Globo-H (MBr1) Glycosylamino Acid: Some Mechanistic and Conformational Reinvestigations

le Zhu, Jianglong, Wan, Qian, Yang, Guangbin, Ouerfelli, Ouathek, Danishefsky, Samuel J.
Foilsithe 2009

Radiosynthesis of the Tumor Hypoxia Marker [(18)F]TFMISO via O-[(18)F]Trifluoroethylation Reveals a Striking Difference Between Trifluoroethyl Tosylate and Iodide in Regiochemical...

le Suehiro, Makiko, Yang, Guangbin, Torchon, Geralda, Ackerstaff, Ellen, Humm, John, Koutcher, Jason, Ouerfelli, Ouathek
Foilsithe 2011

N-Acetylgalactosamino Dendrons as Clearing Agents to Enhance Liver Targeting of Model Antibody-Fusion Protein

le Yoo, Barney, Cheal, Sarah M., Torchon, Geralda, Dilhas, Anna, Yang, Guangbin, Pu, Jun, Punzalan, Blesida, Larson, Steven M., Ouerfelli, Ouathek
Foilsithe 2013

Human Cancer Antigen Globo H Is a Cell-Surface Ligand for Human Ribonuclease 1

le Eller, Chelcie H., Chao, Tzu-Yuan, Singarapu, Kiran K., Ouerfelli, Ouathek, Yang, Guangbin, Markley, John L., Danishefsky, Samuel J., Raines, Ronald T.
Foilsithe in ACS Cent Sci (2015)

Radiosynthesis of [(131)I]IAZGP via nucleophilic substitution and its biological evaluation as a hypoxia marker — is specific activity a factor influencing hypoxia-mapping ability...

le Suehiro, Makiko, Burgman, Paul, Carlin, Sean, Burke, Sean, Yang, Guangbin, Ouerfelli, Ouathek, Oehler-Janne, Christoph, O’Donoghue, Joseph, Ling, Clifton, Humm, John
Foilsithe 2009

From Synthesis to Biologics: Preclinical Data on a Chemistry Derived Anticancer Vaccine

le Zhu, Jianglong, Wan, Qian, Lee, Dongjoo, Yang, Guangbin, Spassova, Maria K., Ouerfelli, Ouathek, Ragupathi, Govind, Damani, Payal, Livingston, Philip O., Danishefsky, Samuel J.
Foilsithe 2009

Evaluation of glycodendron and synthetically-modified dextran clearing agents for multi-step targeting of radioisotopes for molecular imaging and radioimmunotherapy

le Cheal, Sarah M., Yoo, Barney, Boughdad, Sarah, Punzalan, Blesida, Yang, Guangbin, Dilhas, Anna, Torchon, Geralda, Pu, Jun, Axworthy, Don B., Zanzonico, Pat, Ouerfelli, Ouathek, Larson, Steven M.
Foilsithe in Mol Pharm (2013)

A N-acetylgalactosamino Dendron-Clearing Agent for High-Therapeutic Index DOTA-Hapten Pretargeted Radioimmunotherapy

le Cheal, Sarah M., Patel, Mitesh, Yang, Guangbin, Veach, Darren, Xu, Hong, Guo, Hong-fen, Zanzonico, Pat B., Axworthy, Donald B., Cheung, Nai-Kong V., Ouerfelli, Ouathek, Larson, Steven M.
Foilsithe in Bioconjug Chem (2020)

A Phase I Study of Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission

le O’Cearbhaill, Roisin E., Ragupathi, Govind, Zhu, Jianglong, Wan, Qian, Mironov, Svetlana, Yang, Guangbin, Spassova, Maria K., Iasonos, Alexia, Kravetz, Sara, Ouerfelli, Ouathek, Spriggs, David R., Danishefsky, Samuel J., Sabbatini, Paul J.
Foilsithe in Cancers (Basel) (2016)

HSP90 is a therapeutic target in JAK2-dependent myeloproliferative neoplasms in mice and humans

le Marubayashi, Sachie, Koppikar, Priya, Taldone, Tony, Abdel-Wahab, Omar, West, Nathan, Bhagwat, Neha, Caldas-Lopes, Eloisi, Ross, Kenneth N., Gönen, Mithat, Gozman, Alex, Ahn, James H., Rodina, Anna, Ouerfelli, Ouathek, Yang, Guangbin, Hedvat, Cyrus, Bradner, James E., Chiosis, Gabriela, Levine, Ross L.
Foilsithe 2010

Engineered cells as a test platform for radiohaptens in pretargeted imaging and radioimmunotherapy applications

le Dacek, Megan M., Veach, Darren R., Cheal, Sarah M., Carter, Lukas M., McDevitt, Michael R., Punzalan, Blesida, Vargas, Daniela Burnes, Kubik, Thomas Z., Monette, Sebastien, Santich, Brian H., Yang, Guangbin, Ouerfelli, Ouathek, Kesner, Adam L., Cheung, Nai-Kong V., Scheinberg, David A., Larson, Steven M., Krebs, Simone
Foilsithe in Bioconjug Chem (2021)

A Self-Assembling and DisAssembling (SADA) bispecific antibody (BsAb) platform for curative 2-step pre-targeted radioimmunotherapy

le Santich, Brian H, Cheal, Sarah M, Ahmed, Mahiuddin, McDevitt, Michael R, Ouerfelli, Ouathek, Yang, Guangbin, Veach, Darren R, Fung, Edward K, Patel, Mitesh, Vargas, Daniela Burnes, Malik, Aiza A, Guo, Hong-Fen, Zanzonico, Pat B, Monette, Sebastien, Michel, Adam O, Rudin, Charles M, Larson, Steven M, Cheung, Nai-Kong V
Foilsithe in Clin Cancer Res (2020)

Proteasome addiction defined in Ewing’s sarcoma is effectively targeted by a novel class of 19S proteasome inhibitors

le Shukla, Neerav, Somwar, Romel, Smith, Roger S., Ambati, Sri, Munoz, Stanley, Merchant, Melinda, D’Arcy, Padraig, Wang, Xin, Kobos, Rachel, Antczak, Christophe, Bhinder, Bhavneet, Shum, David, Radu, Constantin, Yang, Guangbin, Taylor, Barry S., Ng, Charlotte K.Y., Weigelt, Britta, Khodos, Inna, de Stanchina, Elisa, Reis-Filho, Jorge S., Ouerfelli, Ouathek, Linder, Stig, Djaballah, Hakim, Ladanyi, Marc
Foilsithe in Cancer Res (2016)

Alpha radioimmunotherapy using (225)Ac-proteus-DOTA for solid tumors - safety at curative doses

le Cheal, Sarah M., McDevitt, Michael R., Santich, Brian H., Patel, Mitesh, Yang, Guangbin, Fung, Edward K., Veach, Darren R., Bell, Meghan, Ahad, Afruja, Vargas, Daniela Burnes, Punzalan, Blesida, Pillarsetty, Naga Vara Kishore, Xu, Hong, Guo, Hong-fen, Monette, Sébastien, Michel, Adam O., Piersigilli, Alessandra, Scheinberg, David A., Ouerfelli, Ouathek, Cheung, Nai-Kong V., Larson, Steven M.
Foilsithe in Theranostics (2020)

Opposing reactions in coenzyme A metabolism sensitize Mycobacterium tuberculosis to enzyme inhibition

le Ballinger, Elaine, Mosior, John, Hartman, Travis, Burns-Huang, Kristin, Gold, Ben, Morris, Roxanne, Goullieux, Laurent, Blanc, Isabelle, Vaubourgeix, Julien, Lagrange, Sophie, Fraisse, Laurent, Sans, Stéphanie, Couturier, Cedric, Bacqué, Eric, Rhee, Kyu, Scarry, Sarah M., Aubé, Jeffrey, Yang, Guangbin, Ouerfelli, Ouathek, Schnappinger, Dirk, Ioerger, Thomas R., Engelhart, Curtis A., McConnell, Jennifer A., McAulay, Kathrine, Fay, Allison, Roubert, Christine, Sacchettini, James, Nathan, Carl
Foilsithe in Science (2019)

ARN-509: a novel anti-androgen for prostate cancer treatment

le Clegg, Nicola J., Wongvipat, John, Joseph, Jim, Tran, Chris, Ouk, Samedy, Dilhas, Anna, Chen, Yu, Grillot, Kate, Bischoff, Eric D., Cai, Ling, Aparicio, Anna, Dorow, Steven, Arora, Vivek, Shao, Gang, Qian, Jing, Zhao, Hong, Yang, Guangbin, Cao, Chunyan, Sensintaffar, John, Wasielewska, Teresa, Herbert, Mark R., Bonnefous, Celine, Darimont, Beatrice, Scher, Howard I., Smith-Jones, Peter, Klang, Mark, Smith, Nicholas D., De Stanchina, Elisa, Wu, Nian, Ouerfelli, Ouathek, Rix, Peter J., Heyman, Richard A., Jung, Michael E., Sawyers, Charles L., Hager, Jeffrey H.
Foilsithe 2012